🧪
Healthcare & Biotech 产品技术与架构落后 2017 - 2020

抗生素公司的商业化困境 (Melinta):一家有多款获批抗生素的公司,为什么卖不动?

当药物被有意限制使用,市场规模与商业回报就会脱节

抗生素公司的商业化困境 (Melinta):巅峰期由多家生物技术公司整合而成的抗生素企业,拥有数款获批的抗菌药物与相应的销售团队,在市场上面向医院与感染科医生推广产品;终局是获批产品的销售未能达到预期,公司收入无法覆盖推广与研发费用,在债务压力下申请破产保护并完成重组,股东权益几乎归零,产品与团队被重组后的实体继续运营。

Official site
See the patterns
公开报道整理 待核查 Figures as of 2020 3 sources(1 primary) What do these mean?

How to read this bar

This bar states plainly what we know and what we have checked, so you can judge it yourself.

· Review status: “pending” means no editor has checked it against the sources yet; “checked” means key facts match the sources.

· Figures as of: the year the numbers are current to; later changes are out of scope.

· Sources: listed one by one at the bottom of the page. “Primary” means official filings, annual reports or regulator documents.

· Corrections: every change and its basis is published — nothing is edited silently.

Editorial policy → Editorial policy: the full inclusion rules, verification process, AI disclosure and correction promise.

No English translation for this case yet — showing the stored original.
Peak valuation

由多家生物技术公司整合而成的抗生素企业,拥有数款获批的抗菌药物与相应的销售团队,在市场上面向医院与感染科医生推广产品

Final cost

获批产品的销售未能达到预期,公司收入无法覆盖推广与研发费用,在债务压力下申请破产保护并完成重组,股东权益几乎归零,产品与团队被重组后的实体继续运营

Attribution votes

2,493 votes cast

Community output

1 plans · 1 insights

Sponsored
把你亲历的失败写进来

投稿会先进入待审,通过后才进入公开目录和站点地图。

Root Causes Consensus Poll

Vote for the primary fatal error that caused this enterprise to collapse.

产品技术

产品的使用量被临床规范限制

为控制耐药性,医疗机构有意限制使用,市场规模有限

820 votes (33%)
战略

推广成本与市场规模不匹配

覆盖大量医院与专科医生的销售成本高于收入

689 votes (28%)
资本财务

通过收购整合产品并承担债务

整合需要时间验证协同,而债务成本立即发生

558 votes (22%)
外部合规

对支付与采购条件的依赖

收入取决于医院采购与支付安排,缺少定价空间

426 votes (17%)

Sources

3 sources · 1 primary

These are the references used to compile this case; the numbers match the [1][2] marks in the timeline. Primary sources come first, and archive links are kept where possible.

1 of these are overseas sites (Wikipedia, the Internet Archive, etc.) that may be unreachable from mainland China, so domestic sources (Baidu Baike, mainstream financial media, exchange filings) have been added wherever possible.

  1. [1]
    官方网站(Wikidata 登记) Primary 官方资料
    rib-x.com Accessed 2026-10-04
  2. [2]
    维基百科:Melinta Therapeutics 其他 Overseas site
    Wikipedia Accessed 2026-10-04
  3. [3]
    抗生素、消炎药,到底有什么区别?-新华网 媒体报道
    新华网 Accessed 2026-10-05